Ozempic & GLP-1 litigation — safety & in… | DrugsMonitor.com

Clinical summary and reported injury patterns for Ozempic & GLP-1 litigation. Links to FDA recalls and litigation overview. Not medical advice.

semaglutide, tirzepatide, Wegovy, Mounjaro, Rybelsus, gastroparesis, intestinal obstruction

Clinical context

GLP-1 受体激动剂（索马鲁肽、利拉鲁肽、替泽帕肽）据称会导致某些使用者出现严重的胃轻瘫、梗阻、胆囊疾病和胰腺炎。

Litigation context

宾夕法尼亚州东区 MDL No. 3094； 发现和领头羊计划将持续到 2026 年。